ALLISON DUNCAN: Open Payments
NPI 1235457938 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,160 in 53 payments from 14 companies in 2025. Trend: 2023 $1,247 · 2024 $3,033 · 2025 $1,160
Food & beverage: $1,160
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $253 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $198 |
| ABBVIE INC. | 13 | $188 |
| Novo Nordisk Inc | 1 | $124 |
| Ipsen Biopharmaceuticals, Inc | 4 | $76 |
| GENZYME CORPORATION | 3 | $54 |
| Ardelyx, Inc. | 3 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Exact Sciences Corporation | 1 | $43 |
| QOL Medical, LLC | 2 | $34 |
Products named: TREMFYA, ENTYVIO, Wegovy, RINVOQ, DUPIXENT, LINZESS, IQIRVO, IBSRELA.
Industry payments across NY — which companies pay providers there.
